Skip to main content
OpenTrials

Clinical trial condition

Wilms Tumor

Explore clinical trials studying Wilms Tumor. Study availability and eligibility vary by location and protocol.

159 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Wilms Tumor trial results

Completed

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor

NCT00379340

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +16 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
View all 227 locations
View Trial Details
Completed

Pharmacogenetic Study of Antimitotic Therapies Involved in Hepatic VOD in Children With Nephroblastoma or ALL

NCT04168788

Conditions
Acute Lymphoblastic Leukemia, Cardiovascular Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +30 more
Locations
  • Univesity Hostipal of Amiens Amiens, France
  • University Hospital of Bordeaux Bordeaux, France
  • University of Brest Brest, France
  • Centre Oscar Lambret Lille, France
View Trial Details
Completed

Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor

NCT00945009

Conditions
Abnormalities, Multiple, Adult Kidney Wilms Tumor, Beckwith-Wiedemann Syndrome, +28 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 169 locations
View Trial Details
Completed

Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor

NCT00352534

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +17 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
View all 240 locations
View Trial Details
Completed

Study of Kidney Tumors in Younger Patients

NCT00898365

Conditions
Adenocarcinoma, Adult Cystic Nephroma, Anaplastic Kidney Wilms Tumor, +46 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
View all 248 locations
View Trial Details
Completed

Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)

NCT03213678

Conditions
Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, +82 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 127 locations
View Trial Details
Completed

Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)

NCT03213665

Conditions
Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Hodgkin Lymphoma, Ann Arbor Stage III Non-Hodgkin Lymphoma, +91 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
View all 117 locations
View Trial Details

Related conditions